Related Experiment Video
Updated: Oct 16, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
Published on: September 20, 2024
Generalizability of Homeopathic Prognostic Factor Research Outcome in COVID-19 Treatment: Comparison of Data
Lex Rutten1, Anjali Miglani2, Peter Gold3
1Independent Researcher, Breda, The Netherlands.
Insights
Homeopathic prognostic factor research (PFR) projects during COVID-19 showed consistency. Minor conflicts between studies were explainable, indicating a strong global consensus among homeopathic practitioners.
Area of Science:
- Homeopathy Research
- Epidemiology
- Evidence-Based Medicine
Background:
- Several homeopathic prognostic factor research (PFR) projects were conducted during the COVID-19 pandemic.
- This study aimed to assess the consistency and identify potential flaws in these PFR projects.
Purpose of the Study:
- To compare outcomes of different homeopathic prognostic factor research (PFR) projects during the COVID-19 pandemic.
- To evaluate the consistency and identify potential causes of discrepancies in PFR findings.
Main Methods:
- Two comparisons were performed: (1) LMHI database (100 doctors, 541 cases) vs. prior analysis (161 cases). (2) Updated LMHI database vs. Indian data collection (4 doctors, 1,445 cases).
- Conflicting outcomes were examined for potential causes, including statistical variations, observer bias, and prescribing practices.
Main Results:
- A single conflicting outcome was found within the LMHI database, likely due to statistical variation.
- Six out of 72 comparisons (8.3%) showed conflicting outcomes between the LMHI and Indian datasets.
- Potential causes for discrepancies included small sample sizes, observer variability, confirmation bias, and inadequate symptom checking.
Conclusions:
- Little conflict was observed between different versions of the same PFR project and between the two distinct PFR projects.
- Most discrepancies could be attributed to manageable factors, suggesting a strong overall consensus among homeopathic practitioners globally.
- Variations in consensus were noted between smaller groups of practitioners.
Background/Objective:
During the coronavirus disease 2019 (COVID-19) pandemic, several homeopathic prognostic factor research (PFR) projects have been undertaken. We found two projects with comparable outcomes to assess consistency and possible flaws.
Methods:
Two comparisons were made. (1) Outcome of a PFR data collection from the Liga Medicorum Homoeopathica Internationalis (LMHI) by about 100 doctors with 541 cases was compared with a previous analysis of 161 cases in the same database. (2) The updated LMHI database was also compared with a data collection carried out in India by four doctors with a total of 1,445 cases. Differences that resulted in conflicting outcomes (indication in one, contraindication in the other) were examined for possible causes.
Results:
There was only a single outcome in the updated LMHI database that conflicted with the previous dataset, and this could have been due to statistical variation. The Indian data contained many cases, from few doctors, while the LMHI database had few cases per doctor, but many doctors. The overlap between the projects (individual cases entered in both) was between zero and 22%. In 72 comparisons we found six (8.3%) conflicting outcomes. Possible causes were statistical error due to small numbers of cases and/or observers, confirmation bias, and keynote prescribing if this resulted in symptoms being inadequately checked.
Conclusion:
There was little conflict between the outcomes of the two versions of one project and between the two different PFR projects. Differences could mostly be explained by causes that can be managed. This consistency should primarily be interpreted as showing a strong overall consensus between homeopathic practitioners worldwide, but with variation of consensus between small groups of practitioners.
More Related Videos
Related Concept Videos
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Comparing the Survival Analysis of Two or More Groups
Regression Toward the Mean
Bioequivalence of Drugs: Drugs with Multiple Indications
Hazard Ratio
For example, in a clinical trial...
Factors Affecting Illness
For instance, risk factors are connected to illness,...

